ID Board Review/Fungi
Jump to navigation
Jump to search
Fungi account for 5% of the ABIM ID Certification Exam.[1] Based off the ABIM blueprint, therapies, specific diagnostic testing and syndromes may be emphasized more than Bacterial or Viral Diseases.
Yeasts[edit | edit source]
- Candida spp
- Cryptococcus
- Other yeasts
- Trichosporon
- Saccharomyces
Endemic mycoses[edit | edit source]
- Histoplasma
- Blastomyces dermatitidis
- Coccidioides spp
- Coccidioides immitis
- Coccidioides posadasii
- Sporothrix schenckii
- Paracoccidioides brasiliensis
- Talaromyces marneffei (Previously Penicillium marneffei)
Molds[edit | edit source]
Superficial and subcutaneous mycoses[edit | edit source]
- Mycetoma
- Chromoblastomycosis
- Malassezia
- Dermatophytes
Pneumocystis jirovecii pneumonia (PJP)[edit | edit source]
Therapy[edit | edit source]
- Pharmacokinetics
- Drug interactions
- Spectrum
- Toxicity
- Prophylaxis
- Susceptibility testing
- Drug resistance
Diagnostic testing[edit | edit source]
- Histopathology
- Culture
- Nonculture methods
Syndromes[edit | edit source]
- Mucosal
- Skin
- Pulmonary
- Central nervous system and eyes
- Cardiac
- Disseminated